# DEC3-VEN vs. Venetoclax-Based vs. DA Regimens in Newly Diagnosed AML

> clinical trial · VERIFIED · 2026-07-20

Status: RECRUITING · Sponsor: The Second Affiliated Hospital of Kunming Medical University · Condition: AML (Acute Myeloid Leukemia)

- Company: The Second Affiliated Hospital of Kunming Medical University
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT07712848

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.